Tue, 09 Jun 2009 15:07:44 -0400 PeerView Neurology CME/CNE/CPE Video Podcast PeerView Press http://www.peerviewpress.com Podcast Maker v1.3.8b - http://www.lemonzdream.com/podcastmaker Thought leader perspectives on current clinical advances in medicine. PeerView Press is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. en-us 2007 PeerView Press,24 West 40th Street, Suite 950, New York, NY 10018 webmaster@peerviewpress.com http://podcast.peerviewpress.com/NeurologyVideo/VidNeurologyCME-CNE-CPE_144.jpg PeerView Neurology CME/CNE/CPE Video Podcast http://www.peerviewpress.com 144 144 Science & Medicine CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Neurology no Scott H. Kollins, PhD, MS - Insights on Adult ADHD: Recognition, Diagnosis, and Treatment PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this activity, experts in the management of adult ADHD discuss the challenges in diagnosing and treating ADHD in adults. http://podcast.peerviewpress.com/NeurologyVideo/PA03852FCr421.mp3 http://podcast.peerviewpress.com/NeurologyVideo/PA03852FCr421.m4v Fri, 20 Mar 2009 15:07:25 -0400 Science, Medicine no 00:47:45 Attention-deficit/hyperactivity disorder, ADHD, impulsivity, hyperactivity, anxiety, depression, substance abuse, stimulant therapy, nonstimulant therapy, cognitive-behavioral therapy CME/CNE/CPE Information - Insights on Adult ADHD: Recognition, Diagnosis, and Treatment PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/NeurologyVideo/PA03852FCCMEinfo.pdf http://podcast.peerviewpress.com/NeurologyVideo/PA03852FCCMEinfo.pdf Fri, 20 Mar 2009 15:07:11 -0400 Science, Medicine no 00:00:00 Attention-deficit/hyperactivity disorder, ADHD, impulsivity, hyperactivity, anxiety, depression, substance abuse, stimulant therapy, nonstimulant therapy, cognitive-behavioral therapy Brett R. Stacey, MD - A Case-Based Approach to Recognizing and Managing Diabetic Peripheral Neuropathy PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this activity, an expert in painful DPN discusses differential diagnosis of the condition and management approaches in treatment-naïve patients as well as in individuals with established diagnosis. http://podcast.peerviewpress.com/NeurologyVideo/PA05052FCp151.mp3 http://podcast.peerviewpress.com/NeurologyVideo/PA05052FCp151.m4v Mon, 09 Mar 2009 14:03:52 -0400 Science, Medicine no 00:27:54 diabetic peripheral neuropathy, DPN, diabetes, neuropathic pain, nerve damage, pregabalin, duloxetine, diagnosis CME/CNE/CPE Information - A Case-Based Approach to Recognizing and Managing Diabetic Peripheral Neuropathy PeerView Press Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/NeurologyVideo/PA05052FCCMEinfo.pdf http://podcast.peerviewpress.com/NeurologyVideo/PA05052FCCMEinfo.pdf Mon, 09 Mar 2009 14:03:48 -0400 Science, Medicine no 00:00:00 diabetic peripheral neuropathy, DPN, diabetes, neuropathic pain, nerve damage, pregabalin, duloxetine, diagnosis Bruce A. Cree, MD, PhD, MCR - New Data From the World Congress: First-Line Therapy, Modified Treatment, and Emerging Options in Multiple Sclerosis PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, 3 experts discuss the latest updates in management of multiple sclerosis, based on data presented at the 2008 World Congress for the Treatment and Research of Multiple Sclerosis (WCTRMS 2008). http://podcast.peerviewpress.com/NeurologyVideo/PA04910FCs496.m4v http://podcast.peerviewpress.com/NeurologyVideo/PA04910FCs496.m4v Fri, 31 Oct 2008 10:39:42 -0400 Science no 00:49:12 multiple sclerosis, gadolinium-enhancing lesions, glatiramer acetate, interferon, immunomodulatory therapy, natalizumab CME/CE Information - New Data From the World Congress: First-Line Therapy, Modified Treatment, and Emerging Options in Multiple Sclerosis PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/NeurologyVideo/PA04910FCCMEinfo.pdf http://podcast.peerviewpress.com/NeurologyVideo/PA04910FCCMEinfo.pdf Fri, 31 Oct 2008 10:38:42 -0400 Science no 00:00:00 multiple sclerosis, gadolinium-enhancing lesions, glatiramer acetate, interferon, immunomodulatory therapy, natalizumab David Geldmacher, MD - Advances in Alzheimer's Disease and Vascular Dementia: Benchmarks in Diagnosis and Treatment PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this CME/CE activity, experts in the management of dementia present recent data on the diagnosis and treatment of Alzheimer's disease and vascular dementia. http://podcast.peerviewpress.com/NeurologyVideo/PA04467FCr379.m4v http://podcast.peerviewpress.com/NeurologyVideo/PA04467FCr379.m4v Mon, 18 Aug 2008 15:04:03 -0400 Science no 00:59:15 memantine, rivastigmine, galantamine, donepezil, cholinesterase inhibitors, NMDA-receptor antagonist, Alzheimer's disease, vascular dementia, mild cognitive impairment, MRI CME/CE Information - Advances in Alzheimer's Disease and Vascular Dementia: Benchmarks in Diagnosis and Treatment PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/NeurologyVideo/PA04467FCCMEinfo.pdf http://podcast.peerviewpress.com/NeurologyVideo/PA04467FCCMEinfo.pdf Mon, 18 Aug 2008 15:04:03 -0400 Science no 00:00:00 memantine, rivastigmine, galantamine, donepezil, cholinesterase inhibitors, NMDA-receptor antagonist, Alzheimer's disease, vascular dementia, mild cognitive impairment, MRI Robert M. Bennett, MD - Optimal Management of Fibromyalgia: A Multidisciplinary Roundtable Discussion PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this CME/CE activity, experts in the management of FMS discuss diagnosis and management of this complex disorder. Strategies for collaboration between multiple specialties in the treatment of patients with FMS are also highlighted. http://podcast.peerviewpress.com/NeurologyVideo/PA04412FCe016.m4v http://podcast.peerviewpress.com/NeurologyVideo/PA04412FCe016.m4v Fri, 18 Jul 2008 10:48:10 -0400 Science no 01:06:37 Tender points, duloxetine, pregabalin, gabapentin, milnacipran, pramipexole, exercise, pain, cognitive-behavioral therapy, EULAR, ACR, depression, sleep CME/CE Information - Optimal Management of Fibromyalgia: A Multidisciplinary Roundtable Discussion PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/NeurologyVideo/PA04421FCCMEinfo.pdf http://podcast.peerviewpress.com/NeurologyVideo/PA04412FCCMEinfo.pdf Fri, 18 Jul 2008 10:47:10 -0400 Science no 00:00:00 Tender points, duloxetine, pregabalin, gabapentin, milnacipran, pramipexole, exercise, pain, cognitive-behavioral therapy, EULAR, ACR, depression, sleep Patricia K. Coyle, MD - Concepts in the Treatment of MS: New Data on Standard Approaches and Future Possibilities PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this CME activity, experts in the treatment of multiple sclerosis consider recent studies on the early treatment of MS. Long-term data on safety and efficacy and head-to-head comparisons of available therapies are presented. http://podcast.peerviewpress.com/NeurologyVideo/PA04011FCr378.m4v http://podcast.peerviewpress.com/NeurologyVideo/PA04011FCr378.m4v Thu, 03 Jul 2008 09:55:45 -0400 Science no 00:30:30 MS, interferon, glatiramer acetate, mitoxantrone, natalizumab, PRISMS, CHAMPS, CHAMPIONS, ETOMS, REFLEX, BENEFIT, PRECISE CME/CE Information - Concepts in the Treatment of MS: New Data on Standard Approaches and Future Possibilities PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/NeurologyVideo/PA04011FCCMEinfo.pdf http://podcast.peerviewpress.com/NeurologyVideo/PA04011FCCMEinfo.pdf Thu, 03 Jul 2008 09:51:46 -0400 Science no 00:00:00 MS, interferon, glatiramer acetate, mitoxantrone, natalizumab, PRISMS, CHAMPS, CHAMPIONS, ETOMS, REFLEX, BENEFIT, PRECISE Georgia Montouris, MD - Managing Epilepsy in Women PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this CME/CE activity, experts in the treatment of epilepsy discuss the management of this condition in women. Recent data on bone and reproductive health in women with epilepsy are reviewed. http://podcast.peerviewpress.com/NeurologyVideo/PA03785FCr374.m4v http://podcast.peerviewpress.com/NeurologyVideo/PA03785FCr374.m4v Fri, 18 Apr 2008 14:52:06 -0400 Science no 00:28:27 Phenytoin, vitamin D, DEXA, calcium, valproate, benzodiazepines, zonisamide, ethosuximide, lamotrigine, pregabalin, gabapentin, carbamazepine, topiramate CME/CE Information - Managing Epilepsy in Women PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/NeurologyVideo/PA03785FCCMEinfo.pdf http://podcast.peerviewpress.com/NeurologyVideo/PA03785FCCMEinfo.pdf Fri, 18 Apr 2008 14:52:03 -0400 Science no 00:00:00 Phenytoin, vitamin D, DEXA, calcium, valproate, benzodiazepines, zonisamide, ethosuximide, lamotrigine, pregabalin, gabapentin, carbamazepine, topiramate Emmanuelle L. Waubant, MD, PhD - Recognizing and Anticipating Therapy-Related Adverse Events in Multiple Sclerosis PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of multiple sclerosis present the most current safety data associated with the use of broad-spectrum immunomodulatory/immunosuppressive agents and monoclonal antibodies in multiple sclerosis. In addition, the investigational status of oral therapies in MS is clarified. http://podcast.peerviewpress.com/NeurologyVideo/PA04137FCsr359.m4v http://podcast.peerviewpress.com/neurology/PA04137FCr359.m4v Fri, 25 Jan 2008 14:45:28 -0500 Science no 00:30:48 Multiple sclerosis, Interferon beta, Glatiramer acetate, Mitoxantrone, Cyclophosphamide, Azathioprine, Mycophenolate mofetil, Natalizumab, Rituximab, Daclizumab, Alemtuzumab, Cladribine, Fingolimod, Teriflunomide, Laquinimod, BG-12, Dimethyl fumarate CME/CE Information - Recognizing and Anticipating Therapy-Related Adverse Events in Multiple Sclerosis PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/NeurologyVideo/PA04137FCCMEinfo.pdf http://podcast.peerviewpress.com/neurology/PA04137FCCMEinfo.pdf Fri, 25 Jan 2008 14:44:28 -0500 Science no 00:00:00 Multiple sclerosis, Interferon beta, Glatiramer acetate, Mitoxantrone, Cyclophosphamide, Azathioprine, Mycophenolate mofetil, Natalizumab, Rituximab, Daclizumab, Alemtuzumab, Cladribine, Fingolimod, Teriflunomide, Laquinimod, BG-12, Dimethyl fumarate Amit Bar-Or, MD, FRCP - Data Updates for Monoclonal Antibodies in Multiple Sclerosis PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of multiple sclerosis discuss data presented at the 23rd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2007) concerning the use of the monoclonal antibodies natalizumab, rituximab, daclizumab, and alemtuzumab in this disorder. http://podcast.peerviewpress.com/NeurologyVideo/PA03646FC3s430.m4v http://podcast.peerviewpress.com/NeurologyVideo/PA03646FC3s430.m4v Fri, 11 Jan 2008 17:31:01 -0500 Science no 00:25:58 Multiple sclerosis,Alemtuzumab,Natalizumab,Rituximab,Daclizumab,Monoclonal antibody,T cell,B cell,Epstein-Barr virus (EBV), Neuromyelitis optica,European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) CME/CE Information - Data Updates for Monoclonal Antibodies in Multiple Sclerosis PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/NeurologyVideo/PA03646FC3CMEinfo.pdf http://podcast.peerviewpress.com/NeurologyVideo/PA03646FC3CMEinfo.pdf Fri, 11 Jan 2008 17:30:57 -0500 Science no 00:00:00 Multiple sclerosis,Alemtuzumab,Natalizumab,Rituximab,Daclizumab,Monoclonal antibody,T cell,B cell,Epstein-Barr virus (EBV), Neuromyelitis optica,European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Stephen L. Hauser, MD - Treatment Guidelines and Targeted Options for Multiple Sclerosis PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, expert neurologists discuss the guidelines for an evidence-based use of broad-spectrum immunomodulatory therapies in multiple sclerosis and the rationales for integrating targeted therapies into the management of the disease. http://podcast.peerviewpress.com/NeurologyVideo/PA03646FC2r341.m4v http://podcast.peerviewpress.com/NeurologyVideo/PA03646FC2r341.m4v Thu, 25 Oct 2007 10:58:02 -0400 Science & Medicine no 00:30:34 Alemtuzumab. Antibody, antichimeric, Antibody, monoclonal, Antibody, neutralizing, B cell, CD20, CD56, Daclizumab, Glatiramer acetate, Idiopathic thrombocytopenic purpura (ITP), Interferon beta, Interleukin 2 (IL-2), Mitoxantrone, Multiple sclerosis CME/CE Information - Treatment Guidelines and Targeted Options for Multiple Sclerosis PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/NeurologyVideo/PA03646FC2CMEinfo.pdf http://podcast.peerviewpress.com/NeurologyVideo/PA03646FC2CMEinfo.pdf Thu, 25 Oct 2007 10:58:01 -0400 Science & Medicine no 00:00:00 Alemtuzumab. Antibody, antichimeric, Antibody, monoclonal, Antibody, neutralizing, B cell, CD20, CD56, Daclizumab, Glatiramer acetate, Idiopathic thrombocytopenic purpura (ITP), Interferon beta, Interleukin 2 (IL-2), Mitoxantrone, Multiple sclerosis Bruce Cree, MD, PhD, MCR - Emerging, Targeted Treatment Options in Multiple Sclerosis PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, expert neurologists discuss the rationales for integrating targeted therapies into the management of multiple sclerosis (MS). Specifically, recently reported efficacy and safety data are discussed regarding the use of natalizumab, daclizumab, rituximab, and alemtuzumab in patients with MS. http://podcast.peerviewpress.com/NeurologyVideo/PA03646FCr326.m4v http://podcast.peerviewpress.com/NeurologyVideo/PA03646FC%20r326.m4v Wed, 08 Aug 2007 15:32:52 -0400 Science & Medicine no 00:30:42 Alemtuzumab, B cell, Daclizumab, Glatiramer acetate, Idiopathic thrombocytopenic purpura (ITP), Interferon beta, Interleukin-2 receptor, Mitoxantrone, Monoclonal antibody, Multiple sclerosis, Natalizumab, Progressive multifocal leukoencephalopathy (PML) CME/CE Information - Emerging, Targeted Treatment Options in Multiple Sclerosis PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/NeurologyVideo/PA03646FCCMEinfo.pdf http://podcast.peerviewpress.com/NeurologyVideo/PA03646FC1r326CMEinfo.pdf Wed, 08 Aug 2007 15:32:50 -0400 Science & Medicine no 00:00:00 Alemtuzumab, B cell, Daclizumab, Glatiramer acetate, Idiopathic thrombocytopenic purpura (ITP), Interferon beta, Interleukin-2 receptor, Mitoxantrone, Monoclonal antibody, Multiple sclerosis, Natalizumab, Progressive multifocal leukoencephalopathy (PML) Perry G. Fine, MD - Pain Management With Opioids: Enhancing Communication for Better Outcomes PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, pain management experts discuss chronic pain therapy with prescription opioids by focusing on the enhancement of communication between the patient and healthcare professional. Specifically, tactics for facilitating communication are presented, as well as strategies for overcoming typical obstacles to successful pain management. http://podcast.peerviewpress.com/NeurologyVideo/PA03728FCs338.m4v http://podcast.peerviewpress.com/NeurologyVideo/PA03728FCs338.m4v Thu, 24 May 2007 13:49:22 -0400 Science & Medicine no 00:27:18 Pain, chronic pain, opioid, noncancer pain, methadone, codeine, fentanyl, oxycodone, hydrocodone, propoxyphene, communication, cognitive impairment, addiction, JCAHO CME/CE Information - Pain Management With Opioids: Enhancing Communication for Better Outcomes PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/NeurologyVideo/PA03728FCCMEinfo.pdf http://podcast.peerviewpress.com/NeurologyVideo/PA03728FCCMEinfo.pdf Thu, 24 May 2007 13:48:52 -0400 Science & Medicine no 00:00:00 Pain, chronic pain, opioid, noncancer pain, methadone, codeine, fentanyl, oxycodone, hydrocodone, propoxyphene, communication, cognitive impairment, addiction, JCAHO